- UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
- Leukemia Symposium: Focus on Opportunities to Improve Care
- 2018 Pan Pacific Lymphoma Conference
- 13th Annual Fall Midwest Thoracic and GI Oncology Conference
- Events
Playback speed
10 seconds
CLL Therapy in 2020 - Ibrutinib+ Rituximab Provides Superior PFS and OS, Fixed Duration Venetoclax/Obinutuzumab, Acalabrutinib Safe and Effective
322 views
March 9, 2020
Comments 0
Login to view comments.
Click here to Login
Hematology Highlights: A Post ASH Review